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Methicillin-
resistant
Staphylococcus
aureus Necrotizing
Pneumonia
To the Editor: Methicillin-resist-
ant  Staphylococcus aureus (MRSA)
strains account for >40% of all hospi-
tal-acquired  S. aureus infections in
Italy (1). Although cases of communi-
ty-acquired MRSA (CA-MRSA)
infections have been reported in
recent years (2), these isolates have
not been characterized for Panton-
Valentine leukocidin (PVL) (3); there-
fore, the presence of isolates with the
typical characteristics of CA-MRSA
(4) in Italy remains unknown. 
At the beginning of April 2005, a
37-year-old woman was admitted to
the University Hospital Policlinico in
Rome because of fever, cough, and
headache. Her medical history was
unremarkable. She was a teacher in a
school for foreign students in Rome,
smoked 3 cigarettes per day for 15
years, and reported no recent travel
abroad. Her 5-year-old daughter had
influenzalike symptoms in the previ-
ous week. At hospital admission, her
temperature was 39°C, heart rate was
108 beats/min, respiratory rate was 32
breaths/min, and blood pressure was
105/70 mmHg. Arterial blood gas
analysis showed mild hypoxemia and
hypocapnia (PaO2 73 mm Hg and
PaCO2 34 mm Hg on room air).
Leukocyte count was 24,360 cells/µL
(81% polymorphonuclear cells), and
platelet count was 506,000/µL. Chest
radiograph showed infiltrates in the
right upper and lower lobes and left
lower lobe. Empiric treatment with
clarithromycin and ceftriaxone was
started, but the patient’s clinical con-
ditions did not improve. Culture of
sputum samples obtained at admis-
sion yielded growth of MRSA.
Computed tomographic scan showed
multiple lung cavitary lesions, indi-
cating necrotizing pneumonia. On day
3 of admission, antimicrobial drug
therapy was changed to linezolid (600
mg 3 times a day). Fever resolved,
and the patient’s condition rapidly
improved. The patient was discharged
after 14 days of linezolid treatment.
At discharge, leukocyte count was
6,040 cell/µL (58% polymorphonu-
clear cells), and arterial blood gas
analysis showed PaO2 of 88 mm Hg.
The MRSA isolate from sputum
was susceptible to all the non–β-lac-
tam antimicrobial drugs tested,
including erythromycin, clindamycin,
ciprofloxacin, tetracycline, kanamy-
cin, and fusidic acid. With established
molecular methods, the isolate was
found to harbor SCCmec type IV (5);
lukS and lukF, the genes coding for
the 2 subunits of the PVL toxin; and
hlg, the γ-hemolysin gene (3). The
genetic background of the isolate was
determined by multilocus sequence
typing (MLST) (6) and sequence typ-
ing of the tandem repeat region of
protein A gene (spa  typing) (7).
Results showed that the isolate
belonged to ST30 according to the
MLST database (http://saureus.
mlst.net), and spa typing, analyzed by
the Ridom Staphtype software
(http://www.ridom.de), indicated a
novel spa type, to which type 755 was
assigned. ST30, 1 of 6 clones more
commonly associated with PVL-posi-
tive CA-MRSA(4), is designated also
the southwest Pacific (SWP) clone,
because of the area in which it circu-
lates. Recently, the SWP clone has
caused CA-MRSA infections in
northern European countries
(England, Scotland, the Netherlands,
Sweden, and Latvia) (8,9). Molecular
analysis suggests that the SWP clone
has evolved from a methicillin-sus-
ceptible clone of S. aureus, termed
phage type 80/81, that was pandemic
in the 1950s and considered to be
unusually virulent and transmissible
(8). In fact, strains belonging to phage
type 80/81 carry the PVL gene and
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appear to have subsequently acquired
methicillin resistance through hori-
zontal transfer of SCCmec type IV.
The  spa type of the Italian isolate
comprises 7 nucleotide repeats, indi-
cated by XJ4AKAOM in the alpha-
betical code. This repeat sequence dif-
fers from that of the classical SWP
clone, indicated by XKAKAOMQ
(8), by only 1 bp in the second repeat
and loss of the last Q repeat. In spite
of these differences, the spa type is in
substantial agreement with the MLST
result and indicates that the Italian
isolate is either a descendent or a local
variant of the SWP clone. The most
common clone of CA-MRSA
described in Europe is ST80, spa type
44. CA-MRSA belonging to ST80
tend to be more antimicrobial drug
resistant than isolates belonging to
other clones (4). Resistance to fusidic
acid, typical of ST80, has been pro-
posed as a marker for CA-MRSA in
Europe (10). In light of our finding,
we cannot rely on resistance to fusidic
acid to screen for PVL-producing
CA-MRSA in our country.
To our knowledge, this is the first
report from Italy of necrotizing pneu-
monia caused by PVL-positive CA-
MRSA. The presentation was typical-
ly that of a severe pneumonia that
occurred in a previously healthy,
young adult with no risk factors for
MRSA acquisition, as described in
other cases (11). This is also the first
report of a SWP clone isolate in
southern Europe; if the strain is circu-
lating in Italy or is occasionally
imported from the SWP area, whether
our patient acquired it through contact
with a foreign contact remains
unknown.
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West Nile Virus
Infection and
Conjunctival
Exposure
To the Editor: Corvids (crows,
blue jays, magpies, and their rela-
tives) are particularly susceptible to
West Nile virus (WNV) (1). Birds are
useful indicators of the spread of
WNV (1), and Canada has imple-
mented WNV surveillance strategies
that use these species as sentinels. 
Direct acquisition of WNV
through percutaneous injuries has
been reported in 2 laboratory circum-
stances, involving a blue jay and a
mouse (2). We describe a conjunctival
exposure to WNV that occurred in the
field and probably resulted in infec-
tion in the exposed person.
As part of the local WNV bird sur-
veillance activities in 2003, an animal
control officer collected sick and dead
corvids at the Canadian Forces Base,
Suffield, Alberta. He had a protective
suit on, but he wore no mask or face
shield. While killing an injured crow
(Corvus brachyrhynchos), the officer
struck the struggling bird on a nearby
horizontal pipe gate, which resulted in
fracture of the skull, causing brain tis-
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